On 2026-08-04 08:11:09 (Saudi Time), Dallah Healthcare Co. announced its Interim financial results for the six months ended on June 30, 2026.

Year-on-Year Performance Drivers

For H1-2026, Dallah Healthcare's sales/revenue rose 11.9% YoY to SAR 2,121.16 million (from SAR 1,895.19 million), primarily driven by a 17.2% increase in patient visits reaching 1.976 million, strong revenue growth of 112.2% from newly consolidated Dallah Al-Khobar and Dallah Al-Ahsa Hospitals (consolidated from 23 March 2025), and an improved mix of specialized medical services. However, net profit attributable to shareholders declined 34.1% YoY to SAR 184.53 million (from SAR 279.82 million), largely due to SAR 79.2 million in net negative non-recurring items — including SAR 15.3 million in Mina Emergency Hospital operating costs in 2026 versus a SAR 12.5 million zakat provision reversal and SAR 51.4 million real estate fund gains in 2025 — compounded by a SAR 44.5 million increase in operating costs from the consolidation of the two acquired hospitals and SAR 24.06 million higher financing costs tied to the Group's acquisition program.

Quarter-on-Quarter Performance Drivers

QoQ revenue rose 9.3% to SAR 1,107.90 million (vs. SAR 1,013.26 million in Q1-2026), driven by a 10.4% increase in patient visits (1.037 million vs. 939 thousand), as operational activity rebounded following the Ramadan slowdown, with the Central Region accounting for 76.9% of the visit increase. Net profit attributable to shareholders grew 18.3% QoQ to SAR 100.01 million (vs. SAR 84.52 million), supported by a SAR 53.28 million increase in gross profit from stronger revenues, which lifted operating profit by SAR 44.2 million (excluding non-recurring items); however, a non-recurring charge of SAR 15.3 million in operating costs for the Mina Emergency Hospital during the Hajj season partially offset the gains, such that adjusted net profit rose 36.5% to SAR 115.34 million.

Other Items

Dallah Healthcare Co.'s interim financial results for the six months ended June 30, 2026 received an unmodified conclusion from the external auditor, with no additional comments, reservations, or other matters noted. The report contains no material risk warnings regarding going concern or debt default. Total shareholders' equity (after deducting minority equity) stood at SAR 4,130.139 million as of the current period, compared to SAR 4,134.628 million in the same period of the previous year, a marginal decline of 0.108%. Earnings per share for H1-2026 were SAR 1.827, down from SAR 2.815 in H1-2025. The company noted that it will allocate the majority of proceeds from the sale of its stake in Dr. Mohammed Rashed Al Faqih Company — of which SAR 466.7 million was received in July 2026 — to reduce outstanding borrowings, which the company stated in the announcement "is expected to positively reflect on the financial statements of upcoming periods."

Original announcement:

Attached PDF document link:

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.